Not yet recruiting
Breast cancer
Not yet recruitingEvaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients
Registered drug
Evaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients
Registered drug
- Disease:Breast cancer
- Substances:Cefazolin SodiumSodium Chloride Ph. Eur.+1
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Cefazolin Sodium
- Sponsor:University Hospital Of Clermont-Ferrand
